In a significant diplomatic intervention aimed at the highest levels of global governance, Brazilian President Luiz Inácio Lula da Silva and World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus have issued a joint appeal to the leaders of the G7, G20, and BRICS nations. The letter, sent from Brasília and Geneva, calls for the immediate finalization of the Pathogen Access and Benefit-Sharing (PABS) annex, described as the "last piece of the puzzle" for the historic WHO Pandemic Agreement. This call to action comes as international negotiators prepare for a decisive session from July 6 to July 17, following a period of deadlock over how the world shares biological data and the medical tools derived from it.
The joint statement emphasizes that while the world has made significant strides in health cooperation since the peak of the COVID-19 pandemic, the legal framework required to prevent a repeat of the 2020-2023 crisis remains incomplete. The leaders argue that without the PABS system, the international community remains vulnerable to fragmented responses, vaccine inequity, and economic instability. They specifically requested that heads of state provide their negotiators with the political mandate to reach a consensus, stressing that "solidarity is our best immunity" and that the agreement does not infringe upon national sovereignty.
The Pathogen Access and Benefit-Sharing (PABS) Framework
At the heart of the current diplomatic push is the PABS system, a mechanism designed to ensure that when a country identifies a new and dangerous pathogen, it shares the genetic information and physical samples with the global scientific community. In return, the system is intended to guarantee that the resulting vaccines, diagnostics, and treatments are shared fairly with the providing nations and those in need, rather than being hoarded by wealthier states.
According to the joint letter, the PABS annex is the critical operational detail that transforms the Pandemic Agreement from a set of principles into a functional tool. The system aims to replace the "case-by-case" improvisation that characterized the early response to COVID-19 with a stable, predictable framework. This predictability is seen as essential for both public health officials and the pharmaceutical industry, providing legal certainty for laboratories while ensuring that equity is not treated as "charity" but as a strategic necessity for global containment.
A Chronology of the Pandemic Agreement Negotiations
The journey toward a global pandemic treaty began in the wake of the devastating losses of the COVID-19 pandemic. The timeline of these negotiations reflects both the urgency felt by the international community and the complexity of reconciling diverse national interests:
- May 2021: At the 74th World Health Assembly, Member States agreed to discuss the development of a WHO convention or agreement on pandemic preparedness.
- December 2021: A Special Session of the World Health Assembly formally established an Intergovernmental Negotiating Body (INB) to draft and negotiate the "WHO CA+" (Pandemic Accord).
- 2022–2023: Multiple rounds of negotiations took place in Geneva, focusing on surveillance, "One Health" approaches, and the strengthening of national health systems.
- May 2024: The 77th World Health Assembly convened with the goal of adopting the agreement. While significant progress was made on many articles, the PABS annex remained a major sticking point, leading Member States to extend the mandate of the INB.
- July 2024: The upcoming session (July 6–17) is viewed by the WHO and the Brazilian presidency of the G20 as the definitive window to close the remaining gaps before the momentum of the post-COVID era fades.
Supporting Data: The Human and Economic Cost of Unpreparedness
The urgency expressed by President Lula and Dr. Tedros is backed by sobering data from international institutions. The joint letter cites WHO estimates that the COVID-19 pandemic claimed as many as 20 million lives globally. Beyond the human toll, the economic impact was catastrophic. The International Monetary Fund (IMF) estimates that the pandemic cost the global economy more than $13 trillion in lost output. These losses were felt across every sector, from shuttered businesses and broken supply chains to a "lost generation" of students who faced years of disrupted education.
Current scientific modeling suggests that the risk of another pandemic is not a distant possibility but an imminent threat. Researchers estimate there is a nearly 25% chance of another pandemic of similar scale to COVID-19 occurring within the next decade. Factors such as climate change, shifting land-use patterns, and the evolution of intensive agriculture are redrawing the "hotspot" maps for zoonotic spillovers—where diseases jump from animals to humans. Furthermore, the rapid advancement of biotechnology, while offering life-saving potential, increases the risks associated with accidental laboratory releases if biosafety standards are not harmonized globally.
Addressing Concerns Over Sovereignty and Mandates
A significant portion of the joint letter is dedicated to debunking misinformation regarding the Pandemic Agreement’s impact on national sovereignty. Critics in several nations have expressed concern that the agreement would grant the WHO the power to impose lockdowns, travel restrictions, or mandatory vaccinations.
President Lula and Dr. Tedros addressed these concerns directly, pointing to Article 22, paragraph 2 of the draft agreement. The text explicitly states that nothing in the Agreement gives the WHO the authority to direct or alter a country’s domestic laws or policies. Decisions regarding public health measures such as lockdowns remain strictly within the purview of sovereign states. The leaders emphasized that the PABS annex is a tool for cooperation and resource-sharing, not a mechanism for global governance over individual citizens.
Geopolitical Dynamics: The Roles of G7, G20, and BRICS
The decision to address the letter to the G7, G20, and BRICS reflects the shifting landscape of global health diplomacy. Brazil, currently holding the G20 presidency, has been a vocal advocate for viewing inequality as a primary driver of pandemic vulnerability. Under Brazil’s leadership, the G20 recently recognized that health disparities between the Global North and Global South hinder the world’s collective ability to contain outbreaks at their source.
The G7 nations, representing the world’s largest developed economies and the hubs of the pharmaceutical industry, have expressed concerns regarding intellectual property rights and the financial obligations associated with the PABS system. Conversely, the BRICS nations and the broader Global South have insisted that any agreement must include binding commitments for technology transfer and equitable access to medical countermeasures. The joint letter seeks to bridge this divide by framing equity as a "strategy" rather than a moral obligation, arguing that containing a virus where it emerges is significantly cheaper in both lives and resources than fighting a globalized pandemic.
Official Responses and Stakeholder Perspectives
While the official responses from the G7 and BRICS secretariats are pending the outcome of the July negotiations, various stakeholders have already signaled their positions. Public health NGOs, such as Médecins Sans Frontières (MSF) and the People’s Vaccine Alliance, have echoed the call for a strong PABS annex, warning that a "weak" agreement would leave the world in the same state of "vaccine apartheid" seen during the rollout of COVID-19 vaccines.
On the other hand, industry groups representing pharmaceutical manufacturers have cautioned that the PABS system must not undermine the incentives for innovation. They argue that rapid access to pathogen data is essential, but that mandatory sharing of intellectual property could slow down the development of the very vaccines the agreement seeks to distribute. The July session will require negotiators to find a middle ground that ensures both rapid innovation and fair distribution.
Broader Impact and Long-term Implications
The finalization of the WHO Pandemic Agreement and its PABS annex would represent a landmark achievement in international law, comparable to the eradication of smallpox or the global efforts to end polio. It would codify the lessons learned from the COVID-19 pandemic into a permanent structure of global defense.
The implications of failure are equally significant. President Lula and Dr. Tedros warned that every month the annex remains unfinished is a month the world remains "less ready than it could be." They pointed to the ongoing Ebola outbreaks in Africa as a reminder that the threat is not theoretical. Without a centralized, agreed-upon framework, the world remains reliant on voluntary contributions and ad-hoc diplomacy, which have historically proven insufficient during the exponential growth phase of a viral outbreak.
As the July 17 deadline approaches, the focus of the international community shifts to the negotiating table in Geneva. The joint appeal from the leaders of Brazil and the WHO serves as a reminder that the technical hurdles remaining are secondary to the political will required to overcome them. The goal is to move beyond the "rawness of grief" that followed COVID-19 and toward a structured, equitable, and legally binding system that ensures the world is never again caught unprepared by a biological threat.
